• 1
    Unites States Renal Data System (USRDS) 2004 Annual data report. Am J Kidney Dis 2005;45: 8280.
  • 2
    K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39: S1266.
  • 3
    Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al.: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003;139: 137–147.
  • 4
    Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, et al.: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36: 1542–1548.
  • 5
    Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, et al.: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105: 2259–2264.
  • 6
    Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275: 1489–1494.
  • 7
    McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103: 368–375.
  • 8
    Dangas G, Iakovou I, Nikolsky E, Aymong E, Mintz G, et al.: Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Med 2005;95: 1319.
  • 9
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999;130: 461470.
  • 10
    Reinecke H, Fobker M, Wellmann J, Becke B, Fleiter J, et al.: A randomized trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for prevention of contrast media-induced nephropathy: The dialysis-versus-diuresis-(DVD) trial. Clin Res Cardiol 2007;96: 130–139.
  • 11
    Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, et al.: ACC/AHA guidelines for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2001;103: 3019–3041.
  • 12
    Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, et al.: Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 2003;63: 696701.
  • 13
    Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, et al.: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351: 1285–1295.
  • 14
    Manjunath G, Sarnak MJ, Levey AS: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001;10: 785792.
  • 15
    Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, et al.: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67: 2089–2100.
  • 16
    Reinecke H, Brandenburg V, Dominiak P: Recommendations for diagnosis and therapy of patients with coronary heart disease and chronic kidney disease. Clin Res Cardiol Suppl 2006;1: 830.
  • 17
    Hemmelgarn B, Southern D, Hunpries K, Culleton B, Knudtson M, et al.: Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J 2006;27: 1191–1197.
  • 18
    The Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: A position statement. MJA 2005;183: 138141.
  • 19
    Smilde TDJ, van Veldhuisen DJ, Navis G, Voors AA, Hillege HHL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006;114: 15721580.